federal_register: E8-27896

All Federal Register documents (rules, proposed rules, notices, presidential documents) from 1994 to present. Nearly 1M documents with full-text search.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

document_number title type abstract publication_date pub_year pub_month html_url pdf_url agency_names agency_ids excerpts regulation_id_numbers
E8-27896 Draft Guidance for Industry on the Contents of a Complete Submission for the Evaluation of Proprietary Names; Availability Notice The Food and Drug Administration (FDA) is announcing the availability of a draft guidance for industry entitled "Contents of a Complete Submission for the Evaluation of Proprietary Names." This draft guidance provides recommendations to industry regarding the submission of a complete package that FDA intends to use to assess the safety of proposed proprietary drug and biological product names and other factors that, in association with the name, can contribute to medication errors. In addition, FDA intends to use this information in the assessment of promotional aspects of proposed proprietary names. 2008-11-24 2008 11 https://www.federalregister.gov/documents/2008/11/24/E8-27896/draft-guidance-for-industry-on-the-contents-of-a-complete-submission-for-the-evaluation-of https://www.govinfo.gov/content/pkg/FR-2008-11-24/pdf/E8-27896.pdf Health and Human Services Department; Food and Drug Administration 221,199 The Food and Drug Administration (FDA) is announcing the availability of a draft guidance for industry entitled "Contents of a Complete Submission for the Evaluation of Proprietary Names." This draft guidance provides recommendations to industry...  

Links from other tables